Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas

Carcinogenesis

Volumn 25, Issue 4, 2004, Pages 527-533

  Fransén, Karin ^a   Klintenäs, Maria ^a   Österström, Anna ^a,b   Dimberg, Jan ^b   Monstein, Hans Jürg ^c   Söderkvist, Peter ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b JÖNKÖPING UNIVERSITY   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PROTEIN KINASE;

ADULT; AGED; ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; EXON; FEMALE; GENE MUTATION; GENETIC CONSERVATION; GENETIC VARIABILITY; GERM LINE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRON; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SOMATIC MUTATION; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; BASE SEQUENCE; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; GERM-LINE MUTATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS A-RAF; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RAF;

EID: 1342299898     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh049     Document Type: Article

References (29)

1. Boyle,P. and Langman,J.S. (2000) ABC of colorectal cancer. Br. Med. J., 321, 805-808.
2. Kinzler,K. and Vogelstein,B. (1996) Lessons from hereditary colorectal cancer. Cell, 87, 159-170.
3. Fearon,E. and Vogelstein,B. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
4. Hanahan,D. and Weinberg,R.A. (2000) The hallmarks of cancer. Cell, 100, 57-70.
5. Campbell,S.L., Khosravi-Far,R., Rossman,K.L., Clark,G.J. and Der,C.J. (1998) Increasing complexity of Ras signalling. Oncogene, 17, 1395-1413.
6. Peyssonnaux,C. and Eychène,A. (2001) The Raf/MEK/ERK pathway: new concepts of activation. Biol. Cell, 93, 53-62.
7. Hageman,C. and Rapp,U.R. (1999) Isotype-specific functions of Raf kinases. Exp. Cell Res., 253, 34-46.
8. Davies,H., Bignell,G.R., Cox,C., Stephens,P., Edkins,S., Clegg,S., Teague,J., Woffendin,H., Garnett,M.J., Bottomley,W. et al. (2002) Mutations of the BRAF gene in human cancer. Nature, 417, 949-954.
9. Rajagopalan,H., Bardelli,A., Lengauer,C., Kinzler,K.W., Vogelstein,B. and Velculescu,V.E. (2002) Raf/Ras oncogenes and mismatch-repair status. Nature, 418, 934.
10. Yuen,S.T., Davies,H., Chan,T.L., Ho,J.W., Bignell,G.R., Cox,C., Stephens,P., Edkins,S., Tsui,W.W., Chan,A.S. et al. (2002) Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res., 62, 6451-6455.
11. 2 genes in human colorectal adenocarcinomas. Cancer Lett., 182, 175-182.
12. Dimberg,J., Hugander,A., Sirsjö,A. and Söderkvist,P. (2001) Enhanced expression of cyclooxygenase-2 and nuclear beta-catenin are related to mutations in the APC gene in human colorectal cancer. Anticancer Res., 21, 911-915.
13. Jansson,A. and Sun,X.F. (2002) Bax expression decreases significantly from primary tumor to metastasis in colorectal cancer. J. Clin. Oncol., 20, 811-816.
14. Sutter,C., Gebert,J., Bischoff,P., Herfarth,C. and von Knebel Doeberitz,M. (1999) Molecular screening of potential HNPCC patients using a multiplex microsatellite PCR system. Mol. Cell Probes, 13, 157-165.
15. Chiang,J.M., Chou,Y.H. and Chou,T.B. (1998) KRAS codon 12 mutation determines the polypoid growth of colorectal cancer. Cancer Res., 58, 3289-3293.
16. Zhang,B.H. and Guan,K.L. (2000) Activation of BRAF kinase requires phosphorylation of the conserved residues Thr598 and Ser601. EMBO J., 19, 5429-5439.
17. Brose,M.S., Volpe,P., Feldman,M., Kumar,M., Rishi,I., Gerrero,R., Einhorn,E., Herlyn,M., Minna,J., Nicholson,A. et al. (2002) BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res., 62, 6997-7000.
18. Naoki,K., Chen,T.-H., Richards,W.G., Sugarbaker,D.J. and Meyerson,M. (2002) Missense mutations of the BRAF gene in human lung adenocarcinoma. Cancer Res., 62, 7001-7003.
19. Bos,J.L., Fearon,E.R., Hamilton,S.R., Verlaan-de Vries,M., van Boom,J.H., van der Eb,A.J. and Vogelstein,B. (1987) Prevalence for ras gene mutations in human colorectal cancer. Nature, 327, 293-297.
20. Smith,G., Carey,F.A., Beattie,J., Wilkie,M.J.V., Lightfoot,T.J., Coxhead,J., Garner,R.C., Steele,R.J.C. and Wolf,C.R. (2002) Mutations in APC, Kirsten-ras and p53 - alternative genetic pathways to colorectal cancer. Proc. Natl Acad. Sci. USA, 99, 9433-9438.
21. Fahy,B. and Bold,R.J. (1998) Epidemiology and molecular genetics of colorectal cancer. Surg. Oncol., 7, 115-123.
22. Papin,C., Denouel,A., Calothy,G. and Eychène,A. (1996) Identification of signalling proteins interacting with BRAF in the yeast two-hybrid system. Oncogene, 12, 2213-2221.
23. Papin,C., Denouel-Galy,A., Laugier,D., Calothy,G. and Eychène,A. (1998) Modulation of kinase activity and oncogenic properties by alternative splicing reveals a novel regulatory mechanism for BRAF. J. Biol. Chem., 273, 24939-24947.
24. Mercer,K., Chiloeches,A., Huser,M., Kiernan,M., Marais,R. and Pritchard,C. (2002) ERK signalling and oncogene transformation are not impaired in cells lacking A-raf. Oncogene, 21, 347-355.
25. Hoang,J.-M., Cottu,P.H., Thuille,B., Salmon,R.J., Thomas,G. and Hamelin,R. (1997) BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res., 57, 300-303.
26. Jass,J.R., Biden,K.G., Cummings,M.C., Simms,L.A., Walsh,M., Schoch,E., Meltzer,S.J., Wright,C., Searle,J., Young,J. et al. (1999) Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathway. J. Clin. Pathol., 52, 455-460.
27. Powell,S.M., Zilz,N., Beazer-Barclay,Y., Bryan,T.M., Hamilton,S.R., Thibodeau,S.N., Vogelstein,B. and Kinzler,K.W. (1992) APC mutations occur early during colorectal tumorigenesis. Nature, 359, 235-237.
28. Sparks,A.B., Morin,P.J., Vogelstein,B. and Kinzler,K.W. (1998) Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res., 58, 1130-1134.
29. Wang,L., Cunningham,J.M., Winters,J.L., Guenther,J.C., French,A.J., Boardman,L.A., Burgart,L.J., McDonell,S.K., Schaid,D.J. and Thibodeau,S.N. (2003) BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair. Cancer Res., 63, 5209-5212.